Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19

Overview

Retrospective single center analyses of COVID-19 patients admitted to the ICU between 01/02/2020 and 31/07/2021.

All adults (\>18 years) with acute hypoxaemic respiratory failure due to diagnosed COVID-19 pneumonia and admitted to ICU from 01/02/2020 until 31/07/2021 were included in the study. Following the World Health Organisation (WHO) protocol 19, laboratory confirmation of COVID-19 infection was defined as a positive result on polymerase chain reaction (PCR) assays of nasopharyngeal swab samples or bronchoalveolar lavage. Only laboratory-confirmed patients were included in the analysis. Additional data collection Additional collected parameters are listed below and are collected as a standard-of-care in our hospital: * Demographics: i.e age, gender, BMI * DNR code * Comorbidities: smoking, obesity, hypertension, diabetes, cardiovascular disease, respiratory disease, malignancies, renal failure (AKI), liver failure, gastrointestinal disease, neurological conditions, mental state, other * Symptoms at the time of admission to ICU: i.e fever, body temperature, dyspnoea, headache, diarrhea etc… * Laboratory results of all standard parameters measured * Treatment: antiviral agents, antibiotics, etc… * Complications: shock, heart failure, sepsis, stroke, etc… * Ventilation: method, PEEP, FiO2, P/F ratio ..

Conditions

Interventions

Eligibility

Locations (1)

Outcomes